Estimating Prevalence of COVID-19 Infection and SARS-CoV-2 Antibodies in MS Patients

Clinical trial NCT04682548 · COMPLETED

Trial details

NCT number: NCT04682548
Sponsor: NYU Langone Health
Status: COMPLETED
Study type: OBSERVATIONAL

Multiple Sclerosis Covid19

Start date: 2021-01-05
Primary completion: 2022-09-15
Enrollment: 920

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.